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Abstract 
 
Voltage-gated sodium channels (VGSCs) play an important role in neuronal excitability. 
Regulation of VGSC activity is a complex phenomenon that occurs at multiple levels in the cell, 
including transcriptional regulation, post-translational modification and membrane insertion and 
retrieval. Multiple VGSC subtypes exist that vary in their biophysical and pharmacological 
properties and tissue distribution. Any alteration of the VGSC subtype profile of a neuron or the 
mechanisms that regulate VGSC activity can cause significant changes in neuronal excitability. 
Inflammatory and neuropathic pain states are characterised by alterations in VGSC subtype 
composition and activity in sensory neurons. This review focuses on the VGSC subtypes 
involved in such pain states. 
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Introduction 
 
Voltage-gated Na+ channels (VGSCs) are large transmembrane proteins that mediate the rising phase of the action 
potential in excitable cells. VGSCs consist of an α-subunit which forms a Na+-conducting pore and associated β-
subunits that modulate the biophysical properties of the channel. Although it has been known since the late 1940s 
that movement of Na+ across the membrane mediate action potentials in excitable cells, it was not until 1984 that the 
first VGSC α-subunit was cloned from the electric eel Electrophorus electricus (Noda et al., 1984). Since then, nine 
mammalian VGSC α-subunit subtypes have been identified. These vary in their tissue distribution, biophysical 
properties and their sensitivity to neurotoxins. VGSCs are generally classified as either tetrodotoxin (TTX)-sensitive 
(TTX-S) or TTX-resistant (TTX-R) (see Table 1). Four auxiliary β-subunits of approximately 35 kDa have been 
identified: β1 (with the variant β1A), β2, β3 and β4 (Wood, Boorman, Okuse, & Baker, 2004). 
The combination of VGSC subtypes expressed in individual cells is a key determinant of the membrane 
excitability, conduction velocity and possibly in some tissues also the resting membrane potential. Alterations in the 
activity or expression of VGSCs subtypes leading to hyperexcitability are associated with several disease states such 
as epilepsy, stroke and pain. In particular, chronic pain states are known to involve alterations of VGSC activity and 
subtype composition in sensory neurons. This brief review describes the structure, function and regulation of 
VGSCs with the focus on VGSC subtypes involved in inflammatory and neuropathic pain. 
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Structure of VGSCs 
 
The VGSC α-subunits of approximately 260 kDa consist of more than 1800 amino acids with four internally 
homologous domains, each of which contains six membrane-spanning helices (S1–S6) (Fig. 1) (Noda et al., 1984). 
During an action potential, the VGSC transits through at least three states; closed, open and inactivated. Activation 
of the VGSC is mediated by the S4 helix of each domain, whereas inactivation is mediated by a motif located on the 
cytoplasmic side of the channel in the intracellular loop that connects domains III and IV. The loop between 
segment S5 and S6, called the P-loop, is thought to mediate the cation selectivity of the open channel (Catterall, 
2000). VGSC α- and β-subunits interact mainly through their extracellular domains, most likely in the configuration 
1α:2β. All β-subunits adopt the immunoglobulin-like fold with an intracellular C-terminus, one membrane-spanning 
domain and two extracellular β-sheets. β1 and β3 are non-covalently attached to the α-subunit, whereas β2 and β4 
are connected via disulfide bonds (Isom, 2001).  
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Expression, activation and turnover 
 
Neuronal VGSC expression is modulated by growth factors such as nerve growth factor (NGF) and glial-derived 
neurotrophic factor (GDNF). These growth factors up-regulate VGSC mRNA levels, often in a subtype-specific 
manner that depends on the neuronal cell type and growth factor combination (Fjell et al., 1999). Post-translational 
regulation is even more complex and also varies between VGSC α-subunit subtypes. Phosphorylation and auxiliary 
β-subunits can modulate current amplitude as well as the kinetics of transition between the closed, open and 
inactivated state (Isom, 2001). Phosphorylation sites for protein kinase A (PKA) and protein kinase C (PKC) are 
localised in the intracellular loops of the α-subunit (see Fig. 1), and in general, phosphorylation increases the current 
amplitude of TTX-R VGSCs but exerts the opposite effect on TTX-S subtypes (Chahine, Ziane, Vijayaragavan, & 
Okamura, 2005). In addition to regulating the biophysical properties of VGSCs, β-subunits also modulate their cell 
surface levels by anchoring the VGSC to the cytoskeleton (Isom, 2001). In general, little is known about the 
regulation of trafficking and turnover of VGSCs, however, certain regulatory pathways involving membrane 
insertion, stabilisation and retrieval have been described (Fig. 2). Association with ankyrin, annexin II and contactin 
stabilise VGSCs in the membrane and may also increase their trafficking to the cell surface (Chahine et al., 2005). 
On the other hand, ubiquitin ligases of the Nedd4 family target VGSCs for proteasomal destruction, thus reducing 
their membrane density (Fotia et al., 2004).  
 
 
 
Biological function of VGSCs in sensory neurons 
 
Of the nine mammalian VGSC subtypes, six are expressed at high levels in sensory neurons (see Table 1). Sensory 
neurons constitute the first link in the somatosensory pathway and include dorsal root ganglion (DRG) neurons, 
trigeminal ganglion neurons and nodose ganglion neurons. Large DRG neurons (≥35 μm diameter) exhibit fast 
activating and inactivating TTX-S Na+ current and express high levels of Nav1.1, Nav1.2 and Nav1.6. Neurons of 
intermediate size exhibit both TTX-S and TTX-R Na+ currents whereas small neurons (<20 μm diameter) exhibit 
primarily TTX-R Na+ currents. Nav1.7 is expressed throughout DRG neurons of all sizes (Black et al., 1996). The 
two TTX-R Na+ channels, Nav1.8, which produces a slowly inactivating Na+ current (Akopian, Sivilotti, & Wood, 
International Journal of Biochemistry & Cell Biology (2006) 38 (12): 2005-2010. doi: 10.1016/j.biocel.2006.06.008 
 
1996) and Nav1.9, which generates a persistent Na+ current (Dib-Hajj, Tyrrell, Black, & Waxman), are located 
primarily in small DRG neurons, many of which constitute the cell bodies of neurons involved in the transmission of 
pain stimuli (nociception) (Djouhri et al., 2003). The activation kinetics of Nav1.9 are too slow to contribute to the 
action potential, but given that it exhibits a low threshold of activation ( 20 mV more negative than other VGSCs), 
it is likely to have a depolarising effect on the resting membrane potential. In contrast, Nav1.8 exhibits a higher 
threshold of activation (Akopian et al., 1996), which explains why small DRG neurons are normally silent. 
Representative TTX-R (slowly-inactivating and persistent) and TTX-S Na+ currents recorded from isolated rat DRG 
neurons are shown in Fig. 3.  
 
 
 
VGSCs and pain 
 
Pain can be classified as either inflammatory or neuropathic. Inflammatory pain is caused by tissue injury or 
inflammation and can be relieved with drugs such as non-steroid anti-inflammatory drugs, whereas direct damage to 
nerves cause neuropathic pain, which is refractory to normal pain regimes. Significantly, both inflammatory and 
neuropathic pain states are characterised by alterations in VGSC subtype composition and expression in sensory 
neurons. 
 
Nav1.8 and Nav1.7: key players in inflammatory pain 
 
Inflammatory pain states, studied in rodent models injected with inflammatory agents, are characterised by an 
increase in TTX-R Na+ current and a parallel increase in expression of Nav1.8 in DRG neurons (Akopian et al., 
1999). The increase in Nav1.8 expression is believed to be attributed to the increased levels of NGF associated with 
inflammation (Fjell et al., 1999). Other inflammatory mediators also cause phosphorylation of Nav1.8, increasing 
Na+ current amplitude. Phosphorylation also causes a hyperpolarising shift in the voltage-dependence of activation 
and an increase in activation and inactivation rates of Nav1.8 (Wood et al., 2004). An important demonstration of a 
role of Nav1.8 in pain arises from studies of Nav1.8 null mutant mice, which were healthy but exhibited decreased 
responsiveness to noxious mechanical stimuli and reduced inflammatory-induced hyperalgesia. This indicates that 
they exhibited attenuated pain behaviour compared to wild-type mice (Akopian et al., 1999). 
The other VGSC subtype with a significant role in inflammatory pain is Nav1.7. The inflammatory 
disorder, primary erythermalgia, is associated with mutations in the gene encoding Nav1.7 (Yang et al., 2004). A 
recent study of Nav1.7 knockout mice demonstrated a more significant role of this VGSC subtype in inflammatory 
pain than Nav1.8. Global deletion of Nav1.7 is lethal, but when this channel is selectively knocked out in 
nociceptors, mice exhibit reduced or completely abolished pain responses to a range of inflammatory mediators 
(Nassar et al., 2004). 
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Navs and neuropathic pain states 
 
Neuropathic pain is typically studied in animal models of sciatic nerve ligation. These models exhibit changes in 
populations of Nav subtypes expressed in DRG neurons that are almost the opposite of inflammatory pain, that is, a 
reduction in TTX-R Na+ current amplitude and an increase in TTX-S Na+ currents (Hains et al., 2003). The change 
in Na+ current characteristics is accompanied by a decrease in mRNA transcripts for Nav1.8 and Nav1.9, most likely 
due to decreased levels of neurotrophins, and the induction of mRNA for Nav1.3, which is normally only present in 
DRG of embryonic rats (Hains et al., 2003). Nav1.3 mediates a TTX-S Na+ current with rapid kinetics of recovery 
from inactivation, a property that promotes the characteristics of repetitive firing observed in neuropathic pain 
(Hains et al., 2003). The β3 subunit in the DRG is also up-regulated in neuropathic pain models. β3 has been shown 
to accelerate the recovery from inactivation of Nav1.3, and is therefore likely to increase repetitive firing (Shah et 
al., 2000). 
The role of Nav1.8 in neuropathic pain is contentious. Antisense knockdown of Nav1.8 has been shown to 
attenuate neuropathic pain behaviour in rats (Lai et al., 2002). Furthermore, changes in the spatial distribution of 
Nav1.8 from the DRG neuron cell body to the site of injury in the axon have been reported, which may contribute to 
primary sensitisation (Novakovic et al., 1998). In contrast, neuropathic pain behaviour develops normally in Nav1.8 
null mutant mice, arguing against a role for this VGSC subtype in neuropathic pain (Akopian et al., 1999). It was 
initially thought that the development of neuropathic pain in the Nav1.8 null mutant mice was due to compensatory 
up-regulation of Nav1.7. However, recent studies have shown that both the Nav1.7 nociceptor-specific knockout and 
a double Nav1.7/Nav1.8 knockout can develop neuropathic pain (Nassar, Levato, Stirling, & Wood, 2005). 
 
Nav1.9: a possible role in pain states 
 
Although expressed predominantly in neurons identified as nociceptors, the role of Nav1.9 in pain states is ill-
defined. Given the depolarising effect of Nav1.9 on the resting membrane potential, an up-regulation of Nav1.9 may 
shift the membrane potential closer to the activation threshold of other VGSC subtypes, promoting hyperexcitability. 
Conversely, a down-regulation below normal levels (as observed in neuropathic pain), resulting in a more 
hyperpolarised resting potential may reduce steady-state inactivation of other VGSCs (Herzog, Cummins, & 
Waxman, 2001). Therefore, both up- and down-regulation of Nav1.9 may affect neuronal excitability of DRG and 
contribute to different types of pain. Furthermore, G-protein coupled pathways, known to act downstream of 
inflammatory meditors, up-regulate Nav1.9, increasing neuronal excitability (Baker, Chandra, Ding, Waxman, & 
Wood, 2003). 
 
Conclusions 
 
Regulation of VGSC activity in sensory neurons is highly complex due to the existence of multiple VGSC subtypes 
and regulatory pathways. While the precise role of each of the Nav subtypes in pain states remains to be elucidated, 
recent subtype-specific knockout studies have improved our understanding of the pivotal roles of various VGSC 
subtypes in pain. As a result, there is an increased need to find selective inhibitors/modulators of Nav subtypes as 
potential therapeutic agents. Alternative therapeutic strategies could include interfering with protein-protein 
interactions that alter VGSC activity. Thus, the identification of regulatory pathways, such as those involved in 
insertion and retrieval (turnover), may lead to the development of novel therapeutics targeting neuropathic and 
inflammatory pain. These strategies may also involve the use of molecular approaches, such as short interfering 
RNA (siRNA) to specifically silence genes encoding Nav subtypes or their regulatory proteins.  
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